About The Position

Elanco is seeking a Senior Research Scientist for its Non-Clinical Development team. This non-laboratory-based role drives pharmacological strategies in early drug development to profile new chemical and biological entities and advanced therapies. The role focuses on mitigating clinical development risks by bridging in vitro screening and clinical efficacy, and represents translational pharmacology in cross-functional teams. The scientist applies expertise in target pharmacology and therapeutic options to advance pipeline assets and translate findings into clinical development scenarios. The position designs and coordinates translational pharmacological studies; analyzes mechanisms of action, target biology, and disease pathophysiology; and oversees early in vivo profiling programs and external research activities. It defines biomarker strategies and partners with Safety and DMPK experts on PK/PD approaches. The role also performs reverse-translational analyses of clinical data across species, evaluates study failures and development implications, and identifies potential new indications for portfolio compounds. As a subject matter expert in a matrix organization, the scientist collaborates with external academic and industry partners, provides scientific guidance to Marketing, Business Development, and project teams through launch, and stays current with scientific publications and developments in animal health. The position is based at Elanco’s global headquarters in Indianapolis, Indiana, in a hybrid environment, with up to 30% global travel required.

Requirements

  • DVM or PhD in Veterinary Medicine, Medicine, Biology, Biochemistry, or a related field.
  • 1–3 years of early-career professional experience, including relevant postdoctoral training or residency, in pharmaceutical industry research and/or development.
  • Demonstrated expertise in in vivo pharmacology study design and strategic identification of biomarkers for clinical translatability.
  • Fluent in English.
  • Strong intercultural and interpersonal skills, with the ability to work in changing, interdisciplinary scientific teams.
  • Ability to influence Marketing and Business Development stakeholders effectively.
  • Willingness to travel globally up to 30%.

Nice To Haves

  • Background in veterinary internal medicine, dermatology, oncology, pain, metabolic disease, or immunology.
  • Experience collaborating with external partners such as CROs, KOLs, and consultants.
  • Connections to local research hubs such as Purdue or IU.

Responsibilities

  • Design and coordinate translational pharmacological studies to profile compounds.
  • Analyze mechanisms of action, target biology, and disease pathophysiology to generate insights that reduce clinical development risk.
  • Coordinate early in vivo profiling programs across involved disciplines and integrate translational R&D.
  • Provide technical oversight for experimental in vivo studies, including selection of appropriate animal disease models for screening and dose prediction.
  • Define and implement in vitro and in vivo biomarker strategies for target engagement, pharmacodynamics, and safety.
  • Partner with Safety and DMPK experts to develop PK/PD approaches that scientifically justify therapeutic dosing.
  • Perform reverse-translational meta-analyses of clinical data across species.
  • Identify reasons for study failure, evaluate implications for further development, and uncover potential new indications for existing compounds.
  • Serve as the translational pharmacology subject matter expert within a matrix organization.
  • Collaborate with external academic and industry partners to assess in-licensed products.
  • Provide scientific guidance to Marketing, Business Development, and project teams throughout the innovation process through launch.
  • Maintain expertise in relevant publications and animal health industry developments, including by attending international scientific meetings.

Benefits

  • Multiple relocation packages.
  • Two weeklong shutdowns in the US, one in mid-summer and one at year-end, in addition to PTO.
  • 8-week parental leave.
  • 9 Employee Resource Groups.
  • Annual bonus offering.
  • Flexible work arrangements.
  • Up to 6% 401(k) matching.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service